Advertisements

Tenoretic-100/25

Quick links to important sections

Tenoretic-100/25

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Tenoretic-100/25

Quick Facts

Property Description
Active Ingredients Atenolol, Chlortalidone
Form Tablet (Oral solid dosage form)
Pharmacological Class Beta-blocker / Thiazide-like Diuretic Combination
Common Purpose Management of Elevated Arterial Pressure (Hypertension)
Origin Synthetic (Prescription-Only Medicine)

What is Tenoretic-100/25 and What Type of Medicine is It?

Tenoretic-100/25 is defined as a fixed-dose combination product, integrating two chemically distinct active ingredients—Atenolol and Chlortalidone—into a single tablet for oral administration. The product is classified broadly as an antihypertensive agent, intended for the comprehensive management of elevated arterial pressure. The combination utilizes the additive effects of both agents to lower blood pressure. Such dual-mechanism combinations are used for patients whose blood pressure management requires targeting multiple physiological pathways.


Composition: A Dual-Action Pharmacological Class

The medicine’s structure is built upon its two core synthetic components: Atenolol, which functions as a cardioselective beta-blocker, and Chlortalidone, a thiazide-like diuretic. The combination of these two agents in a single formulation is specifically differentiated by its mechanism: the Atenolol component primarily moderates the heart's response, while the Chlortalidone component, known for its sustained duration, promotes the reduction of the body's fluid volume. Other common brand names sharing this exact active ingredient combination include Tenoretic, Tenoretic-50, and Tenoretic-100, though the 100/25 formulation specifically refers to the amount of each component in the tablet.


General Purpose and Core Therapeutic Benefit

The overarching purpose of this medication is to achieve a stable and robust reduction in elevated arterial pressure, which is the central goal when managing hypertension. The combined strategy of simultaneously slowing the heart's activity and reducing fluid volume ensures that the medicine addresses key physiological contributors concurrently. By effectively lowering blood pressure, the drug contributes significantly to diminishing the chronic strain on the heart and blood vessels, which is critical for supporting long-term cardiovascular stability and improving patient outcomes in typical scenarios of uncomplicated high blood pressure.

Advertisements

What side effects are possible with Tenoretic-100/25?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety constraints for Tenoretic-100/25 (Atenolol/Chlorthalidone), as reported in government regulatory documents.


Documented Adverse Reactions

The most frequently reported side effects are generally classified as Common (may affect up to 1 in 10 people) and include bradycardia (slow heart rate), fatigue, cold extremities, and gastrointestinal disturbances. Metabolic changes such as hypokalaemia (low potassium) and hyperuricemia are also classified as common. Less frequent (Rare) effects documented in the nervous system and psychiatric categories include dizziness, headache, mood changes, and nightmares.

Classification Examples of Documented Effects
Common Fatigue, Bradycardia, Cold extremities, Hypokalaemia
Rare Precipitation of Heart Block, Dizziness, Hallucinations, Impotence

Serious Safety Considerations and Contraindications

Official labeling documents specific, clinically significant adverse reactions, including the precipitation of Heart Block, deterioration of Overt Cardiac Failure, and severe conditions like Acute angle-closure glaucoma and hepatic toxicity.

This medication is officially contraindicated in several specific situations and pre-existing conditions:

  • Patients with Hypersensitivity to either active ingredient or sulphonamide-derived drugs.
  • Individuals with severe renal impairment or conditions such as Anuria (absence of urine production).
  • Severe, pre-existing cardiac conditions, including Sinus Bradycardia, Cardiogenic Shock, or Heart Block greater than first degree.

Population and Duration Notes

The medication is contraindicated for use during pregnancy and lactation. It is generally not recommended for use in children and adolescents. Regulatory documents also specify that abrupt discontinuation of the Atenolol component, particularly in patients with coronary artery disease, may lead to serious events such as the exacerbation of angina or myocardial infarction.

Advertisements

Overdose and Emergency Response

Overdose Scope: Documented Manifestations

Overdose with Tenoretic-100/25 may lead to manifestations stemming from both its beta-blocker (atenolol) and diuretic (chlorthalidone) components. Documented presentations include severe bradycardia (slow heart rate) and hypotension (low blood pressure), often accompanied by dizziness, lethargy, nausea, and vomiting. Over-diuresis may cause significant dehydration and critical electrolyte imbalances, such as hypokalemia and hyponatremia, which can contribute to neurological effects.

Severe Outcomes and Emergency Action

A severe overdose is classified in regulatory contexts as life-threatening due to the potential for complications like Cardiogenic Shock, Overt Cardiac Failure, and acute Bronchospasm. The official regulatory guidance states that medical help must be sought immediately for any suspected overdose, even if symptoms are not yet apparent.

Management requires symptomatic and supportive treatment, as no specific antidote is known. Officially described procedures include methods to reduce absorption, such as gastric lavage or activated charcoal, and the administration of specific pharmacological agents to counteract effects, such as intravenous glucose for hypoglycemia. Intensive hospital monitoring of vital signs, ECG, and fluid/electrolyte balance is mandated, particularly for vulnerable patients with underlying renal or hepatic impairment.

Advertisements

Therapeutic Uses of Tenoretic-100/25

What Tenoretic-100/25 Treats: Main Uses and Benefits

The core therapeutic purpose of Tenoretic-100/25 is to manage the chronic, underlying physiological condition of Hypertension (Elevated Arterial Pressure), and it supports long-term stability rather than relieving acute symptomatic distress. The medication is indicated for the treatment of hypertension and is considered relevant for managing high-risk factors associated with cardiovascular events.

This combination medication is generally used to provide control over primary hypertension in adults with mild to moderate high blood pressure, and it is relevant for patients whose pressure may benefit from a combination strategy for effective daily management. This approach directly addresses the Systemic Vascular Over-strain caused by uncontrolled pressure. This supports the goal of achieving a consistent lowering of blood pressure readings.

The common therapeutic domains for this dual-action therapy are in managing persistent high blood pressure and supporting management when monotherapy has been insufficient. By diminishing vascular strain, the medicine supports general well-being during symptomatic phases. This contributes to easing the overall symptom load related to systemic imbalance.

“This combined support is relevant for individuals whose overall health may benefit from a combination approach when a single agent is insufficient.”

Quick Fact: Management of Elevated Arterial Pressure
Common Use Context Long-term daily management of chronic high blood pressure
Target Symptom Domain Systemic Vascular Over-strain (asymptomatic physiological risk factor)
Primary Patient Benefit Supports cardiovascular stability and helps with achieving a consistent lowering of blood pressure readings
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Rules for Tenoretic-100/25

This medication is indicated for Adults with Hypertension. Eligibility is strictly defined by regulatory documents, which establish groups for whom the medicine is contraindicated or not recommended.

Eligibility Status Population Restrictions
Contraindicated Sinus Bradycardia, Heart Block (greater than first degree), Cardiogenic Shock, Uncontrolled Cardiac Failure, Anuria, Metabolic Acidosis, Untreated Pheochromocytoma, or Hypersensitivity to the components or sulfonamide-derived drugs (e.g., chlorthalidone).
Not Recommended Children and Adolescents (under 18 years of age) because safety and efficacy have not been established.
Conditional Use Pregnancy and Lactation are contraindicated. Use with caution is necessary for Impaired Renal Function and Bronchospastic Disorders (like asthma).

The eligibility profile focuses on cardiovascular contraindications and renal status due to the combined action of the beta-blocker and diuretic components. For older adults, age-related changes in organ function may necessitate a dosage adjustment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Tenoretic-100/25 primarily documents Pharmacodynamic (PD) interactions and Exposure-Altering interactions as key constraints. The primary concern is the potential for additive effects on cardiac function and electrolyte balance when co-administered with specific substance categories.


Pharmacodynamic and Exposure Interactions

The combination of Atenolol and Chlorthalidone carries a documented risk of additive depression of atrioventricular (AV) conduction when used with certain Calcium Channel Blockers (like Verapamil or Diltiazem) and Anti-arrhythmics (like Disopyramide). This additive effect may lead to excessive lowering of heart rate.

The diuretic component increases the risk of Lithium toxicity by reducing its renal clearance. Similarly, the risk of hypokalemia is enhanced when co-administered with Corticosteroids.

Regarding exposure, the anti-hypertensive effect may be lessened by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Furthermore, substances that bind in the gastrointestinal tract, such as Bile Acid Sequestrants (Cholestyramine), require a separation of administration to avoid significantly reduced absorption of the active ingredients.


Restrictions and Other Substances

Administration restrictions include mandatory timing rules, where the product must be separated from sequestrants to mitigate exposure alteration. The regulatory profile notes that Alcohol may increase the risk of orthostatic hypotension and that consumption of Orange Juice near dosing may reduce the bioavailability of Atenolol. Cautions are also documented for patients with Impaired Renal Function due to the risk of drug accumulation.

Advertisements

Mechanism of Action

The first component, Atenolol, acts as a competitive antagonist primarily at beta1-adrenergic receptors, which are abundant in cardiac tissue. This interaction prevents the agonistic effects of endogenous catecholamines, thereby modulating the spontaneous depolarization rate of the sinoatrial node and reducing myocardial contractility. In the kidney, beta1 antagonism in the juxtaglomerular apparatus suppresses the release of renin, which is a key upstream enzyme in the Renin-Angiotensin-Aldosterone System (RAAS) cascade.

The second component, Chlorthalidone, modulates renal function by specifically inhibiting the Na^+/ Cl^- cotransporter ( NCC) located on the apical membrane of epithelial cells in the distal convoluted tubule. This blockade reduces the reabsorption of Na^+ and Cl^- ions from the tubular lumen. The resulting increase in osmotically active ions in the lumen leads to a subsequent increase in the passive excretion of water.

The combined pharmacological effects result in a coordinated systemic change. The cardiac beta1 signaling suppression reduces cardiac output and the velocity of cardiac electrical conduction. Simultaneously, the renal inhibition of the Na^+/ Cl^- cotransporter promotes the loss of fluid volume and salts. The overall systemic consequence is a reduction in total peripheral resistance and a decrease in circulating plasma volume.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Tenoretic-100/25 is a fixed-dose combination product for oral administration only. It is intended strictly for the maintenance treatment of elevated arterial pressure and is not indicated for the initial therapy of hypertension.


Standard Dosing and Frequency

Dosing Parameter Official Instruction
Route/Form Oral tablet, swallowed whole.
Frequency Once daily (qDay).
Usual Dose Range One 50 mg Atenolol / 25 mg Chlorthalidone tablet up to one 100 mg Atenolol / 25 mg Chlorthalidone tablet daily.
Timing (Meals) May be taken with or without food.

Procedural and Population Constraints

The dosage must be individualized for the patient, and the fixed combination is typically substituted for the titrated individual components. The effects of a single daily dose persist for at least 24 hours.

  • Renal Impairment: Dose adjustments are mandatory as the elimination of the Atenolol component is closely related to kidney function. For example, when Creatinine Clearance (CrCl) falls to 15–35 mL/min/1.73 m^2, the maximum dose of the Atenolol component is 50 mg daily. The fixed combination is not recommended in severe renal impairment.
  • Pediatric Use: The safety and efficacy of this combination have not been established in children under 18 years of age, and its use is generally not recommended.
  • Discontinuation: The medicine should not be stopped suddenly. If discontinuation is necessary, the process must be carried out gradually (e.g., over a period of about two weeks) under observation. If a dose is missed, the patient should take it as soon as remembered, but not double the dose to catch up.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tenoretic-100/25


Research Evidence for Managing High Blood Pressure

The primary context for research on the atenolol and chlorthalidone combination was studied for elevated arterial pressure, or hypertension. Initial research primarily consisted of Randomized Controlled Trials (RCTs). These studies were structured to examine short-term physiological outcomes that occur when this two-component medicine was observed in the study context, often comparing it against a placebo or against the individual components alone. Researchers in these trials monitored specific physiological shifts, focusing on changes in Systolic and Diastolic Blood Pressure (BP), both when patients were at rest and during light physical exertion.

These short-term studies, which sometimes involved modest sample sizes, research describes patterns where the combination was observed in some studies with lower Blood Pressure readings compared to placebo. They primarily provide insight into short-term changes and contribute to the broader evidence landscape by establishing the measured outcomes monitoring physiological strain or stress during the study period.


Long-Term Studies and Cardiovascular Follow-up

While the short-term trials focus on immediate BP changes, the broader scientific foundation relies on evidence regarding longer-term observation for cardiovascular risk factors. Researchers have explored the occurrence of Major Cardiovascular Events (heart attack and stroke).

The evidence contributing to this area is derived from large-scale Long-term Clinical Outcome Trials that examined the individual drug classes (the diuretic and other beta-blockers) over many years. This long-term outcome research associated with the component drug classes reported patterns related to fewer measured Cardiovascular Events in the observed populations when compared to other study groups.

It is important to note that the long-term evidence concerning the prevention of major Cardiovascular Morbidity and Mortality is largely drawn from these broader studies of the component drug classes and is not based on dedicated, specific long-term outcome trials for this specific fixed-dose combination. Therefore, long-term effects are not fully established directly through trials of this exact combination.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Tenoretic-100/25 (FAQ)

Q: How long does it usually take for Tenoretic-100/25 to start lowering blood pressure?

A: The beta-blocker component, atenolol, can start to reduce heart rate within approximately one hour of administration. According to official information, the strongest measured effect on heart rate may occur within a few hours. A consistent and full reduction in overall blood pressure is often described as taking a few weeks of consistent treatment.


Q: Can Tenoretic-100/25 affect my blood sugar levels?

A: Regulatory documents state that this medication may cause higher levels of sugar (glucose) in the blood than is considered normal. The beta-blocker component may also make it harder to recognize the warning signs of low blood sugar, as it can mask symptoms like a fast heartbeat.


Q: Are there any common foods or drinks that interact with Tenoretic-100/25?

A: Regulatory documents state the medication can be administered with or without food. However, official restrictions are documented for alcohol, which can increase the risk of dizziness or lightheadedness (orthostatic hypotension). No other specific common food interactions are noted in the core regulatory documentation.


Q: Does Tenoretic-100/25 cause swelling that should be reported?

A: Swelling of the ankles or feet can be a reported symptom, which in some cases may be a sign of a serious adverse reaction such as worsening heart failure or kidney issues. Official guidance describes swelling as a sign that is typically monitored. It is noted that new or worsening swelling is a symptom that may warrant attention from a healthcare professional.


Q: Is Tenoretic-100/25 used to treat chest pain (angina)?

A: The fixed-dose combination product is officially indicated for the management of high blood pressure (hypertension). While the single ingredient, atenolol, is indicated for the treatment of angina (chest pain), the combination product label does not list angina as a standalone indication. However, regulatory documents contain warnings about the risk of worsening angina if the medicine is stopped abruptly in patients with coronary disease.


Q: Can I take Tenoretic-100/25 with a multivitamin?

A: There is no specific restriction against taking a multivitamin with this medication in the official labeling. However, interactions are documented for certain substances that bind in the gut, such as bile acid sequestrants, which require a separation of administration by several hours to avoid reduced absorption of the active drug ingredients.


Q: Does Tenoretic-100/25 interact with supplements like potassium or magnesium?

A: The chlorthalidone component is known to affect electrolyte balance and can cause low levels of potassium in the blood. Therefore, potassium levels may be monitored. The official labeling does not specifically mention interactions with potassium or magnesium supplements, but the balance of these electrolytes is affected by the medication.


Q: Is Tenoretic-100/25 typically taken in the morning or at night?

A: Official guidance states the drug is prescribed to be taken once a day at the same time each day. Official information describes that the medication is often administered in the morning or early afternoon, as the diuretic component is active for a substantial period and works to promote urination.


Q: Does taking Tenoretic-100/25 require regular blood tests?

A: Official labeling states that while using this medication, frequent blood tests may be necessary for monitoring. Blood tests may also be frequently necessary to check for signs of potential side effects, such as electrolyte disorders (like low potassium or sodium) and changes in kidney or liver function.


Q: What's the difference between Tenoretic-100/25 and just plain Atenolol?

A: Tenoretic-100/25 is a combination product containing two active ingredients—Atenolol (a beta-blocker) and Chlorthalidone (a diuretic). Plain Atenolol contains only the beta-blocker. The combination is described as using the additive effects of both different drug classes to manage high blood pressure.


Q: Can Tenoretic-100/25 make me feel dizzy or tired?

A: Fatigue (tiredness) is documented in regulatory documents as a common side effect. Dizziness is also listed as a known, less common effect. The product label notes that dizziness or lightheadedness can occur when moving from a lying or sitting position to standing up.


Q: Is it common to have unusual dreams when taking Tenoretic-100/25?

A: Vivid dreams or nightmares are reported adverse reactions for the drug. Official regulatory documents list these effects, classifying them under nervous system or psychiatric disorders.


Q: Is Tenoretic-100/25 considered a long-term medication?

A: The medication is used for the maintenance treatment of high blood pressure, which is a chronic condition. Official documents note that the blood pressure-lowering effects of a single daily dose last for at least 24 hours, consistent with its role in long-term, daily management.


Q: Do older adults use the same dose of Tenoretic-100/25 as younger people?

A: Official guidelines state that the dosage must be individualized for each patient. For older adults, the need for a dosage adjustment is often noted due to age-related changes, particularly reduced kidney function, which can alter how the drug is cleared from the body.


Q: Does Tenoretic-100/25 cause weight gain?

A: While weight gain is not listed as a common side effect in its own right, unusual weight gain is noted in some documents as a sign that, when accompanied by swelling or shortness of breath, may indicate a more serious issue such as worsening heart failure.


Q: Can taking Tenoretic-100/25 affect my libido or sexual function?

A: Impotence and a change in sex drive or performance are documented adverse reactions for this medication. According to official labeling, these are generally classified as rare effects.


Q: Is it okay to take over-the-counter pain relievers while on Tenoretic-100/25?

A: Official interaction warnings note that the anti-hypertensive effect of this medication may be lessened by some Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This group includes some common over-the-counter pain relievers, such as ibuprofen or naproxen.


Q: What type of monitoring is usually done while taking Tenoretic-100/25?

A: Monitoring typically involves frequent assessment of blood pressure. Frequent blood tests may also be necessary to monitor for potential side effects, such as low levels of sodium or potassium in the blood, and to assess kidney and liver function.


Q: Is Tenoretic-100/25 a drug that can be crushed or split?

A: The regulatory documents describe the product as an oral tablet that is intended to be swallowed whole. There is no official information on the fixed-dose combination product that explicitly authorizes the splitting or crushing of the combination tablet.


Q: Are there reported side effects that involve the skin, like a rash?

A: Skin rash is a reported adverse reaction for this medication. Official post-marketing experience also documents that, rarely, a severe allergic reaction that involves a rash, itching, hives, or swelling of the face, lips, or throat has been seen.


Q: What is the evidence that Tenoretic-100/25 helps reduce the risk of heart problems?

A: Evidence concerning the occurrence of major Cardiovascular Morbidity and Mortality is largely derived from broader, long-term studies of the component drug classes (beta-blockers and diuretics). Long-term effects for the prevention of heart problems are not fully established directly through dedicated outcome trials for this specific fixed-dose combination.


Q: Can Tenoretic-100/25 cause muscle cramps or spasms?

A: Muscle cramps are not listed as a side effect directly, but the chlorthalidone component can cause low levels of potassium in the blood. Official documents indicate that leg cramps are listed as a symptom that may be associated with this low potassium level.


Q: Is Tenoretic-100/25 the same as other Atenolol/Chlorthalidone combinations?

A: Products containing the same two active ingredients, atenolol and chlorthalidone, are chemically equivalent. However, they may differ in their non-medicinal ingredients and in the specific amounts of the active components, such as the difference between the 100 text mg/25 text mg and 50 text mg/25 text mg formulations.


Q: Can Tenoretic-100/25 cause dry mouth or changes in taste?

A: Neither dry mouth nor taste change is listed as a common side effect in the official labeling. However, dry mouth is noted in some documents as a possible sign of dehydration, which can occur due to the diuretic component.


Q: Can Tenoretic-100/25 affect my mood or cause depression?

A: Mood changes and depression are documented adverse reactions for this medication. The official regulatory labeling lists depression as a known, though less common, effect.


Q: Is Tenoretic-100/25 safe for people with gout?

A: The chlorthalidone component of the medicine can cause an increase in the amount of uric acid in the blood (hyperuricemia). High uric acid levels may precipitate or worsen gout according to official documents. Therefore, the status of patients with a history of gout is typically monitored closely.


Q: Is this medication often prescribed after a heart attack?

A: The fixed-dose combination is indicated for high blood pressure management. However, the single beta-blocker component, atenolol, is officially indicated to lower the risk of death after a heart attack, and the combination label contains a prominent warning about not stopping abruptly in patients with ischemic heart disease.


Q: Are there specific symptoms that mean I should contact a healthcare professional about my Tenoretic-100/25?

A: Regulatory documents list several signs that may require immediate attention, including severe allergic reactions (such as rash, swelling, or difficulty breathing), new or worsening swelling of the legs or feet, unexplained chest pain, or signs of severe low electrolyte levels like severe weakness and cramps.


Q: Does Tenoretic-100/25 interact with common cold or flu medicines?

A: Interactions are documented for several drug classes that are often included in cold and flu medicines. Specifically, some Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can lessen the blood pressure-lowering effect, and other common agents like decongestants may have their effects altered by the beta-blocker component.

Advertisements

How should Tenoretic-100/25 be stored and disposed of?

Storage and Disposal Requirements

Tenoretic-100/25 tablets must be stored at room temperature and should not be stored above 25 C to maintain stability.

Storage Conditions

Mandatory conditions require the medication to be stored in a dry place and protected from light and moisture. To ensure this, keep the tablets in their original container and the blister packs within the outer carton.

Child Safety and Disposal

It is a universal requirement to keep this medicine out of the sight and reach of children and pets. For disposal, unused or expired tablets must not be thrown away in household trash or flushed down the toilet. Proper disposal should follow local waste management regulations; individuals should consult a pharmacist or local waste authority for guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Tenoretic-100/25 found in:

A-Z Index: